BACKGROUND: The effect of blood component ratios on the survival of patients with traumatic brain injury (TBI) has not been studied. METHODS: A database of patients transfused in the first 24 hours after admission for injury from 22 Level I trauma centers over an 18-month period was queried to find patients who (1) met different definitions of massive transfusion (5 units red blood cell [RBC] in 6 hours vs. 10 units RBC in 24 hours), (2) received high or low ratios of platelets or plasma to RBC units (<1:2 vs. ≥ 1:2), and (3) had severe TBI (head abbreviated injury score ≥ 3) (TBI+). RESULTS: Of 2,312 total patients, 850 patients were transfused with ≥ 5 RBC units in 6 hours and 807 could be classified into TBI+ (n = 281) or TBI- (n = 526). Six hundred forty-three patients were transfused with ≥ 10 RBC units in 24 hours with 622 classified into TBI+ (n = 220) and TBI- (n = 402). For both high-risk populations, a high ratio of platelets:RBCs (not plasma) was independently associated with improved 30-day survival for patients with TBI+ and a high ratio of plasma:RBCs (not platelets) was independently associated with improved 30-day survival in TBI- patients. CONCLUSIONS: High platelet ratio was associated with improved survival in TBI+ patients while a high plasma ratio was associated with improved survival in TBI- patients. Prospective studies of blood product ratios should include TBI in the analysis for determination of optimal use of ratios on outcome in injured patients.
BACKGROUND: The effect of blood component ratios on the survival of patients with traumatic brain injury (TBI) has not been studied. METHODS: A database of patients transfused in the first 24 hours after admission for injury from 22 Level I trauma centers over an 18-month period was queried to find patients who (1) met different definitions of massive transfusion (5 units red blood cell [RBC] in 6 hours vs. 10 units RBC in 24 hours), (2) received high or low ratios of platelets or plasma to RBC units (<1:2 vs. ≥ 1:2), and (3) had severe TBI (head abbreviated injury score ≥ 3) (TBI+). RESULTS: Of 2,312 total patients, 850 patients were transfused with ≥ 5 RBC units in 6 hours and 807 could be classified into TBI+ (n = 281) or TBI- (n = 526). Six hundred forty-three patients were transfused with ≥ 10 RBC units in 24 hours with 622 classified into TBI+ (n = 220) and TBI- (n = 402). For both high-risk populations, a high ratio of platelets:RBCs (not plasma) was independently associated with improved 30-day survival for patients with TBI+ and a high ratio of plasma:RBCs (not platelets) was independently associated with improved 30-day survival in TBI- patients. CONCLUSIONS: High platelet ratio was associated with improved survival in TBI+ patients while a high plasma ratio was associated with improved survival in TBI- patients. Prospective studies of blood product ratios should include TBI in the analysis for determination of optimal use of ratios on outcome in injured patients.
Authors: Rachael A Callcut; Kit N Simpson; Sarah Baraniuk; Erin E Fox; Barbara C Tilley; John B Holcomb Journal: Transfusion Date: 2020-05-01 Impact factor: 3.157
Authors: Ronald Chang; Lindley E Folkerson; Duncan Sloan; Jeffrey S Tomasek; Ryan S Kitagawa; H Alex Choi; Charles E Wade; John B Holcomb Journal: Surgery Date: 2016-10-21 Impact factor: 3.982
Authors: Samuel M Galvagno; Erin E Fox; Savitri N Appana; Sarah Baraniuk; Patrick L Bosarge; Eileen M Bulger; Rachel A Callcut; Bryan A Cotton; Michael Goodman; Kenji Inaba; Terence O'Keeffe; Martin A Schreiber; Charles E Wade; Thomas M Scalea; John B Holcomb; Deborah M Stein Journal: J Trauma Acute Care Surg Date: 2017-06-06 Impact factor: 3.313
Authors: Patrick K Davis; Harsha Musunuru; Mark Walsh; Robert Cassady; Robert Yount; Andrew Losiniecki; Ernest E Moore; Max V Wohlauer; Janet Howard; Victoria A Ploplis; Francis J Castellino; Scott G Thomas Journal: Neurocrit Care Date: 2013-04 Impact factor: 3.210
Authors: Deborah J del Junco; Erin E Fox; Elizabeth A Camp; Mohammad H Rahbar; John B Holcomb Journal: J Trauma Acute Care Surg Date: 2013-07 Impact factor: 3.313
Authors: Francis J Castellino; Michael P Chapman; Deborah L Donahue; Scott Thomas; Ernest E Moore; Max V Wohlauer; Braxton Fritz; Robert Yount; Victoria Ploplis; Patrick Davis; Edward Evans; Mark Walsh Journal: J Trauma Acute Care Surg Date: 2014-05 Impact factor: 3.313
Authors: Carolyn M Hendrickson; Benjamin M Howard; Lucy Z Kornblith; Amanda S Conroy; Mary F Nelson; Hanjing Zhuo; Kathleen D Liu; Geoffrey T Manley; Michael A Matthay; Carolyn S Calfee; Mitchell J Cohen Journal: J Trauma Acute Care Surg Date: 2016-06 Impact factor: 3.313
Authors: Heather F Pidcoke; Steve J McFaul; Anand K Ramasubramanian; Bijaya K Parida; Alex G Mora; Chriselda G Fedyk; Krystal K Valdez-Delgado; Robbie K Montgomery; Kristin M Reddoch; Armando C Rodriguez; James K Aden; John A Jones; Ron S Bryant; Michael R Scherer; Heather L Reddy; Raymond P Goodrich; Andrew P Cap Journal: Transfusion Date: 2013-01 Impact factor: 3.157